POULTON STUART (EVP, Chief Development Officer) received a stock award from KARYOPHARM THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001193125-26-035655
Officer· EVP, Chief Development Officer
Since Mar 2026
+32.41K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
32.41K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+32.41K
Price / share
—
Trade value
—
% of position
48.1%
1/31/2026
67.39K→99.81K
Total
Net shares
+32.41K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | A · Award | +32.41K | — | — | 48.1% | 67.39K | 99.81K |
| Total | +32.41K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported